ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,293.42
      1.81%
      US Tech 100
      17,798.80
      2.35%
      Dow Jones
      39,304.85
      1.40%
      Brent Oil
      78.495
      0.15%
      Bitcoin
      59,446.77
      8.02%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. ProSomnus Inc (OSA) Quote

      ProSomnus Inc

      ProSomnus Inc (OSA)

      OSAI Automation System SpA
      Osaka Gas Co Ltd
      0.47
      0.00
      ( 0.00% )
      Updated: 20:00:00
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.47
      Bid
      0.485
      Ask
      0.5998
      Volume
      -
      0.00 Day's Range 0.00
      0.34505 52 Week Range 1.61
      Market Cap
      7.707M
      Previous Close
      0.47
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      16,398,599
      Dividend Yield
      -
      PE Ratio
      -0.03
      Earnings Per Share (EPS)
      -1.47
      Revenue
      27.65M
      Net Profit
      -24.1M

      About ProSomnus Inc

      Prosomnus Inc is a company engaged in the research of dental medical technology. The Company is principally engaged in the development, manufacture and marketing of precision intraoral medical devices. The Company's products include MicrO2 Sleep and Snore Device, IA Sleep and Snore Device, CA Sleep ... Prosomnus Inc is a company engaged in the research of dental medical technology. The Company is principally engaged in the development, manufacture and marketing of precision intraoral medical devices. The Company's products include MicrO2 Sleep and Snore Device, IA Sleep and Snore Device, CA Sleep and Snore Device, PH Sleep and Snore Device and EVO Sleep and Snore Device, which are used in the treatment and management of mild to moderate obstructive sleep apnea disease. The Company's precision intraoral devices are personalized to each patient's anatomy and treatment plan. Show more

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Website
      www.prosomnus.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      ProSomnus Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker OSA. The last closing price for ProSomnus was $0.47. Over the last year, ProSomnus shares have traded in a share price range of $ 0.34505 to $ 1.61.

      ProSomnus currently has 16,398,599 shares outstanding. The market capitalization of ProSomnus is $7.71 million. ProSomnus has a price to earnings ratio (PE ratio) of -0.03.

      OSA Latest News

      More News

      ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results

      PLEASANTON, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), the leading non-CPAP therapy™ for the treatment of Obstructive Sleep Apnea (OSA), today announced financial...

      March 26 2024
      GlobeNewswire Inc.

      Anticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See Upticks

      In Monday’s pre-market trading, U.S. index futures are mixed, with Wall Street in anticipation of the monetary policy guidelines that the Federal Reserve is expected to release during the...

      March 18 2024
      IH Market News

      ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

      PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today it has...

      March 15 2024
      GlobeNewswire Inc.

      ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea

      PLEASANTON, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced results of its pilot...

      February 22 2024
      GlobeNewswire Inc.

      ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024

      PLEASANTON, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), the leading non-CPAP therapy for the treatment of Obstructive Sleep Apnea (OSA), announced today that it will...

      February 20 2024
      GlobeNewswire Inc.

      ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA

      PLEASANTON, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today that the United...

      January 30 2024
      GlobeNewswire Inc.

      ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices

      PLEASANTON, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced that the company is...

      January 29 2024
      GlobeNewswire Inc.

      ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea

      PLEASANTON, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, welcomes the adoption of...

      January 08 2024
      GlobeNewswire Inc.

      Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices

      PLEASANTON, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, today announced the publication...

      December 19 2023
      GlobeNewswire Inc.

      ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results

      PLEASANTON, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), the leading non-CPAP Obstructive Sleep Apnea Therapy, today announced financial results for...

      November 09 2023
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      26-0.306-39.43298969070.7760.80.4616698460.58796072CS
      52-1.11-70.2531645571.581.610.345057245490.96442101CS
      156-6.6-93.35219236217.079.410.345053769951.01439728CS
      260-6.6-93.35219236217.079.410.345053769951.01439728CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TOIIWOncology Institute Inc
      $ 0.0264
      (63.98%)
      		16k
      MGOLMGO Global Inc
      $ 3.81
      (56.79%)
      		2.19M
      CDTConduit Pharmaceuticals Inc
      $ 0.2517
      (52.55%)
      		272.81M
      HROWHarrow Inc
      $ 33.2199
      (51.14%)
      		2.35M
      GVPGSE Systems Incorporated
      $ 3.97
      (45.42%)
      		1.49M
      OMOutset Medical Inc
      $ 1.3301
      (-60.88%)
      		7.23M
      CDLXCardlytics Inc
      $ 3.00
      (-56.52%)
      		8.71M
      ENTOEntero Therapeutics Inc
      $ 0.2799
      (-55.07%)
      		1.04M
      FBLGFibroBiologics Inc
      $ 2.315
      (-37.94%)
      		318.93k
      EGHT8x8 Inc
      $ 1.635
      (-36.63%)
      		2.85M
      CDTConduit Pharmaceuticals Inc
      $ 0.2517
      (52.55%)
      		272.81M
      NVDANVIDIA Corporation
      $ 103.20
      (4.34%)
      		178.83M
      XPONExpion360 Inc
      $ 0.0898
      (7.54%)
      		134.77M
      SQQQProShares UltraPro Short QQQ
      $ 10.0699
      (-7.02%)
      		108.29M
      APPSDigital Turbine Inc
      $ 2.46
      (37.43%)
      		44.97M

      OSA Discussion

      View Posts
      Renee Renee 2 days ago
      OSAPQ: BK PLAN effective. All shares and warrants cancelled.

      https://otce.finra.org/otce/dailyList?viewType=Deletions
      👍️0
      Renee Renee 3 months ago
      Effective May 9,2024 OSAP will change to OSAPQ, bankruptcy.

      https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
      👍️0
      Renee Renee 4 months ago
      OSA changed to OSAP. Delisted from the Nasdaq to the OTC:

      https://otce.finra.org/otce/dailyList?viewType=Additions
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      OSA here comes 1.20
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      OSA wants 1.20
      👍️0

      Your Recent History

      NASDAQ
      OSA
      ProSomnus
      Delayed Upgrade Clock